ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them

May 16, 1975

Clinical Research Program Announcement

February 13, 1981

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

February 28, 2014

I-ELCAP Moves From Weill Cornell To Arizona State; PIs Move To Mount Sinai.

January 22, 2010

In Brief: Newell Tells Advisory Committee It Isn’t a Lobbying Group, “Accept What We Give You”

April 8, 1977

In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician

March 31, 1989